BackRevelation Biosciences Overview

Revelation Biosciences Current Cash

Track Revelation Biosciences's current cash ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$14.11M
↑ 280.97% YoYΔ $10.41M vs prior year quarter

Peer average

Loading

Revelation Biosciences Current Cash History

Loading

Revelation Biosciences vs. peers: Current Cash Comparison

Loading

Revelation Biosciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Revelation Biosciences (REVB) FAQ

Revelation Biosciences (REVB) currently reports a current cash of $14M as of March 2026. That compares with $3.7M in the prior-year period — up 281.0% year over year. Use the charts on this page to explore Revelation Biosciences's current cash history and peer comparisons.

Revelation Biosciences's current cash increased from $3.7M to $14M — a 281.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Revelation Biosciences reported $14M in current cash as of March 2026. That compares with $3.7M in the prior-year period — up 281.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Revelation Biosciences, and consider following REVB for alerts when major investors trade the stock.